Four researchers from Cancer Center Amsterdam have been awarded funding through the KWF BOOST programme. The grants, worth approximately €150,000 each, will enable researchers to build on promising findings from previous KWF-funded projects and take important next steps towards improving cancer treatments.
KWF has awarded a total of €1.39 million to nine research projects across the Netherlands, four of which are based at CCA!. The BOOST programme supports short-term research projects (18–24 months) that build on previously funded studies. The aim is to accelerate promising research, develop new technologies and improve research models, while also contributing to the reduction or replacement of animal testing.
The four funded CCA projects
Roeland Lameris – Improving immunotherapy for melanoma
Roeland Lameris is developing a melanoma-on-a-chip model that connects a melanoma tumour with a lymph node, allowing immune cells to move between them. By studying how melanoma cells and immune cells interact, he hopes to gain new insights that could contribute to more effective immunotherapy for skin cancer.
Maarten Bijlsma – Understanding treatment responses in oesophageal cancer
Maarten Bijlsma is developing a cell culture model that mimics how oesophageal tumours interact with their surrounding environment. The model will represent both aggressive and less aggressive forms of the disease, helping researchers investigate which drugs work best for different tumour types and how surrounding support cells influence treatment responses.
Laura Swart – Improving chemotherapy for pancreatic cancer
Laura Swart is working on a new pancreatic cancer model that more accurately reflects how the disease develops in patients. The model will help researchers understand why pancreatic tumours respond differently to chemotherapy and explore how treatments could be better tailored to individual patients.
Joke den Haan – Advancing cancer vaccine research
Joke den Haan is building on previous research into cancer vaccines. Her project will investigate whether the vaccine can effectively activate the immune system and slow tumour growth, taking another step towards developing new immunotherapy approaches.
Building on promising research
The four projects are expected to start in 2027. By providing additional funding for research that has already shown promise, the KWF BOOST programme gives our researchers the opportunity to further develop their findings, refine experimental models and explore new approaches to cancer treatment.